Rare Pediatric Disease Priority Review Voucher - Ownership and Business Overview

Life ScienceCompany

Rare Pediatric Disease Priority Review Voucher Ownership

Who owns Rare Pediatric Disease Priority Review Voucher?

Rare Pediatric Disease Priority Review Voucher is owned by United Therapeutics. It was acquired on December 28, 2020.

Rare Pediatric Disease Priority Review Voucher Business Overview

Where is Rare Pediatric Disease Priority Review Voucher headquartered?

Rare Pediatric Disease Priority Review Voucher is headquartered in United States.

What sector is Rare Pediatric Disease Priority Review Voucher in?

Rare Pediatric Disease Priority Review Voucher is a life science company.

Life Science M&A Summary in 2020

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.

Join Mergr to view all 285 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 262 by strategics.

Rare Pediatric Disease Priority Review Voucher (PPRV)


United States,

Rare Pediatric Disease Priority Review Voucher (PPRV) is a provider of biotechnology services.


Company Summary

SECTOR

Life Science

 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Rare Pediatric Disease Priority Review Voucher

Life Science Companies , United States Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for United States Companies

Largest United States Companies , Acquisitive United States Companies , Recently Acquired United States Companies , Recently Sold United States Companies , Private United States Companies , Public United States Companies , Acquired United States Companies , PE Backed United States Companies
Mergr

Product

Company

Legal